Millennium Management »

Travere Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 13M 1.13

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Henderson Group
Shenkman Capital Management
FMR
BlackRock

View all funds holding Travere Therapeutics